Maria A Lankinen1, Alena Stančáková2, Matti Uusitupa1,3, Jyrki Ågren4, Jussi Pihlajamäki1,5, Johanna Kuusisto2,6, Ursula Schwab1,7, Markku Laakso8,9. 1. Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland. 2. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210, Kuopio, Finland. 3. Research Unit, Kuopio University Hospital, Kuopio, Finland. 4. Institute of Biomedicine, Physiology, University of Eastern Finland, Kuopio, Finland. 5. Clinical Nutrition and Obesity Center, Kuopio University Hospital, Kuopio, Finland. 6. Department of Medicine, Kuopio University Hospital, Kuopio, Finland. 7. Internal Medicine, Kuopio University Hospital, Kuopio, Finland. 8. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210, Kuopio, Finland. markku.laakso@kuh.fi. 9. Department of Medicine, Kuopio University Hospital, Kuopio, Finland. markku.laakso@kuh.fi.
Abstract
AIMS/HYPOTHESIS: Our aim was to investigate the fasting proportions of fatty acids and estimated desaturase and elongase activities in three different lipid fractions in plasma, phospholipids (PLs), cholesteryl esters (CEs) and triacylglycerols (TGs), as predictors for the worsening of glycaemia (area under the glucose curve in an OGTT [glucose AUC]) and incident type 2 diabetes in a 5.9 year follow-up of the Metabolic Syndrome in Men population-based cohort. METHODS: Fatty acid proportions were measured in plasma PL, CE and TG fractions in 1,364 Finnish men aged 45-68 years at baseline. The prospective follow-up study included only men who were non-diabetic at baseline and had data available at follow-up (n = 1,302). A total of 71 participants developed new type 2 diabetes during follow-up. RESULTS: After adjusting for confounding factors, total saturated fatty acids, palmitoleic acid (16:1n-7), dihomo-γ-linolenic acid (20:3n-6) and estimated stearoyl-CoA desaturase 1 and Δ(6)-desaturase (D6D) enzyme activities significantly predicted the worsening of glycaemia whereas total polyunsaturated fatty acid, linoleic acid (18:2n-6) and elongase activity predicted a decrease in the glucose AUC. Estimated D6D activity and dihomo-γ-linolenic acid (20:3n-6) were associated with an increased risk of incident type 2 diabetes. Results were consistent across the three different lipid fractions. However, fatty acid proportions in the PL and CE fractions were stronger predictors for glycaemia and incident type 2 diabetes compared with fatty acid proportions in the TG fraction. CONCLUSIONS/ INTERPRETATION: Selected fatty acid proportions of plasma lipid fractions and their ratios, which reflect desaturase and elongase enzyme activities, may be good biomarkers for the worsening of glycaemia and incident type 2 diabetes.
AIMS/HYPOTHESIS: Our aim was to investigate the fasting proportions of fatty acids and estimated desaturase and elongase activities in three different lipid fractions in plasma, phospholipids (PLs), cholesteryl esters (CEs) and triacylglycerols (TGs), as predictors for the worsening of glycaemia (area under the glucose curve in an OGTT [glucose AUC]) and incident type 2 diabetes in a 5.9 year follow-up of the Metabolic Syndrome in Men population-based cohort. METHODS:Fatty acid proportions were measured in plasma PL, CE and TG fractions in 1,364 Finnish men aged 45-68 years at baseline. The prospective follow-up study included only men who were non-diabetic at baseline and had data available at follow-up (n = 1,302). A total of 71 participants developed new type 2 diabetes during follow-up. RESULTS: After adjusting for confounding factors, total saturated fatty acids, palmitoleic acid (16:1n-7), dihomo-γ-linolenic acid (20:3n-6) and estimated stearoyl-CoA desaturase 1 and Δ(6)-desaturase (D6D) enzyme activities significantly predicted the worsening of glycaemia whereas total polyunsaturated fatty acid, linoleic acid (18:2n-6) and elongase activity predicted a decrease in the glucose AUC. Estimated D6D activity and dihomo-γ-linolenic acid (20:3n-6) were associated with an increased risk of incident type 2 diabetes. Results were consistent across the three different lipid fractions. However, fatty acid proportions in the PL and CE fractions were stronger predictors for glycaemia and incident type 2 diabetes compared with fatty acid proportions in the TG fraction. CONCLUSIONS/ INTERPRETATION: Selected fatty acid proportions of plasma lipid fractions and their ratios, which reflect desaturase and elongase enzyme activities, may be good biomarkers for the worsening of glycaemia and incident type 2 diabetes.
Entities:
Keywords:
Fatty acids; Glycemia; Prospective study; Type 2 diabetes
Authors: Manas Kaushik; Dariush Mozaffarian; Donna Spiegelman; JoAnn E Manson; Walter C Willett; Frank B Hu Journal: Am J Clin Nutr Date: 2009-07-22 Impact factor: 7.045
Authors: P Sjögren; J Sierra-Johnson; K Gertow; M Rosell; B Vessby; U de Faire; A Hamsten; M-L Hellenius; R M Fisher Journal: Diabetologia Date: 2007-11-20 Impact factor: 10.122
Authors: Peter Rzehak; Joachim Heinrich; Norman Klopp; Linda Schaeffer; Sebastian Hoff; Günther Wolfram; Thomas Illig; Jakob Linseisen Journal: Br J Nutr Date: 2008-05-15 Impact factor: 3.718
Authors: Geertruida J van Woudenbergh; Adriana J van Ballegooijen; Anneleen Kuijsten; Eric J G Sijbrands; Frank J A van Rooij; Johanna M Geleijnse; Albert Hofman; Jacqueline C M Witteman; Edith J M Feskens Journal: Diabetes Care Date: 2009-08-12 Impact factor: 19.112
Authors: Luke W Johnston; Zhen Liu; Ravi Retnakaran; Bernard Zinman; Adria Giacca; Stewart B Harris; Richard P Bazinet; Anthony J Hanley Journal: J Lipid Res Date: 2018-07-09 Impact factor: 5.922
Authors: Kamalita Pertiwi; Anne J Wanders; Marjolein C Harbers; Leanne K Küpers; Sabita S Soedamah-Muthu; Janette de Goede; Peter L Zock; Johanna M Geleijnse Journal: Diabetes Care Date: 2019-11-14 Impact factor: 19.112
Authors: Amanda M Fretts; Fumiaki Imamura; Matti Marklund; Renata Micha; Jason H Y Wu; Rachel A Murphy; Kuo-Liong Chien; Barbara McKnight; Nathan Tintle; Nita G Forouhi; Waqas T Qureshi; Jyrki K Virtanen; Kerry Wong; Alexis C Wood; Maria Lankinen; Kalina Rajaobelina; Tamara B Harris; Luc Djoussé; Bill Harris; Nick J Wareham; Lyn M Steffen; Markku Laakso; Jenna Veenstra; Cécilia Samieri; Ingeborg A Brouwer; Chaoyu Ian Yu; Albert Koulman; Brian T Steffen; Catherine Helmer; Nona Sotoodehnia; David Siscovick; Vilmundur Gudnason; Lynne Wagenknecht; Sari Voutilainen; Michael Y Tsai; Matti Uusitupa; Anya Kalsbeek; Claudine Berr; Dariush Mozaffarian; Rozenn N Lemaitre Journal: Am J Clin Nutr Date: 2019-04-01 Impact factor: 7.045
Authors: Markku Laakso; Johanna Kuusisto; Alena Stančáková; Teemu Kuulasmaa; Päivi Pajukanta; Aldons J Lusis; Francis S Collins; Karen L Mohlke; Michael Boehnke Journal: J Lipid Res Date: 2017-01-24 Impact factor: 5.922
Authors: Michele M Schantz; Carissa D Powers; Rosemary L Schleicher; Joseph M Betz; Stephen A Wise Journal: Clin Chim Acta Date: 2016-09-20 Impact factor: 3.786
Authors: Adrian J Green; James L Graham; Eduardo A Gonzalez; Michael R La Frano; Syrago-Styliani E Petropoulou; June-Soo Park; John W Newman; Kimber L Stanhope; Peter J Havel; Michele A La Merrill Journal: Reprod Toxicol Date: 2016-07-12 Impact factor: 3.143